Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer

International Journal of Cancer

Volumn 79, Issue 5, 1998, Pages 509-516

  Sho, Masayuki ^a,b   Adachi, Masashi ^b   Taki, Toshihiko ^b   Hashida, Hiroki ^b   Konishi, Takaaki ^b   Huang, Cheng Long ^b   Ikeda, Naoya ^a,b   Nakajima, Yoshiyuki ^a   Kanehiro, Hiromichi ^a   Hisanaga, Michiyoshi ^a   Nakano, Hiroshige ^a   Miyake, Masayuki ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Kitano Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CELL ADHESION MOLECULES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KANGAI-1 PROTEIN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PANCREATIC NEOPLASMS; PLATELET MEMBRANE GLYCOPROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SURVIVAL RATE;

EID: 17344385057     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981023)79:5<509::AID-IJC11>3.0.CO;2-X     Document Type: Article

References (36)

1. ADACHI, M., TAKI, T., IEKI, Y., HUANG, C.L., HIGASHIYAMA, M. and MIYAKE, M., Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res., 56, 1751-1755 (1996).
2. ALMOGUERA, C., SHIBATA, D., FORRESTER, K., MARTIN, J., ARNHEIM, N. and PERUCHO, M., Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53, 549-554 (1988).
3. BRAMHALL, S.R., ALLUM, W.H., JONES, A.G., ALLWOOD, A., CUMMINS, C. and NEOPTOLEMOS, J.P., Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Brit. J. Surg., 82, 111-115 (1995).
4. CAJOT, J.F., SORDAT, I., SILVESTRE, T. and SORDAT, B., Differential display cloning identifies motility-related protein (MRP-1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res., 57, 2593-2597 (1997).
5. CALDAS, C., HAHN, S. A., DA COSTA, L.T., REDSTON, M.S., SCHUTTE, M., SEYMOUR, A.B., WEINSTEIN, C.L., HRUBAN, R.H., YEO, C.J. and KERN, S.E., Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature (Genet.), 8, 27-32 (1994).
6. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
7. DONG, J.T., LAMB, P.W., RINKER-SCHAEFFER, C.W., VUKANOVIC, J., ICHIKAWA, T., ISAACS, J.T. and BARRETT, J.C., KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science, 268, 884-886 (1995).
8. DONG, J.T., SUZUKI, H., PIN, S.S., BOVA, G.S., SCHALKEN, J.A., ISAACS, W.B., BARRETT, J.C. and ISAACS, J.T., Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res., 56, 4387-4390 (1996).
9. GAUGITSCH, H.W., HOFER, E., HUBER, N.E., SCHNABL, E. and BAUMRUKER, T., A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Europ. J. Immunol., 21, 377-383 (1991).
10. GUO, X., FRIESS, H., GRABER, H.U., KASHIWAGI, M., ZIMMERMANN, A., KORC, M. and BÜCHLER, M.W., KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res., 56, 4876-4880 (1996).
11. HEMLER, M.E., MANNTON, B.A. and BERDITCHEVSKI, F., Association of TM4SF proteins with integrins: relevance to cancer. Biochim. biophys. Acta, 1287, 67-71 (1996).
12. HERMANEK, P. and SOBIN, L.H. (eds.), TNM classification of malignant tumor (4th ed.), pp. 71-75, Springer, New York (1992).
13. HIGASHIYAMA, M., DOI, O., KODAMA, K., YOKOUCHI, H., ADACHI, M., HUANG, C.L., TAKI, T., KASUGAI, T., ISHIGURO, S., NAKAMORI, S. and MIYAKE, M., Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Int. J. Cancer, 74, 205-211 (1997).
14. HIGASHIYAMA, M., TAKI, T., IEKI, Y., ADACHI, M., HUANG, C.L., KOH, T., KODAMA, K., DOI, O. and MIYAKE, M., Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res., 55, 6040-6044 (1995).
15. HOHNE, M.W., HALATSCH, M.E., KAHL, G.F. and WEINEL, R.J., Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res., 52, 2616-2619 (1992).
16. HOTTA, H., ROSS, A.H., HUEBNER, K., ISOBE, M., WENDEBORN, S., CHAO, M.V., RICCIARDI, R.P., TSUJIMOTO, Y., CROCE, C.M. and KOPROWSKI, H., Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res., 48, 2955-2962 (1988).
17. IKEYAMA, S., KOYAMA, M., YAMAOKA, M., SASADA, R. and MIYAKE, M., Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J. exp. Med., 177, 1231-1237 (1993).
18. IMAI, T., FUKUDOME, K., TAKAGI, S., NAGIRA, M., FURUSE, M., FUKUHARA, N., NISHIMURA, M., HINUMA, Y. and YOSHIE, O., C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J. Immunol., 149, 2879-2886 (1992).
19. LEBEL-BINAY, S., LAGAUDRIÉRE, C., FRADELIZI, D. and CONJEAUD, H., CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation. J. Immunol., 155, 101-110 (1995).
20. 1 (CD49d/CD29). J. Immunol., 157, 2039-2047 (1996).
21. MASELLIS-SMITH, A. and SHAW, A.R.E., CD9-regulated adhesion: anti-CD9 monoclonal antibody induces pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J. Immunol., 152, 2768-2777 (1994).
22. MIYAKE, M. and HAKOMORI, S., A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. Biochemistry, 30, 3328-3334 (1991).
23. MIYAKE, M., KOYAMA, M., SENO, M. and IKEYAMA, S., Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-45, which inhibits cell motility. J. exp. Med., 174, 1347-1354 (1991).
24. MIYAKE, M., NAKANO, K., IEKI, Y., ADACHI, M., HUNANG, C.L., ITOI, S., KOH, T. and TAKI, T., Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res., 55, 4127-4131 (1995).
25. MIYAKE, M., NAKANO, K., ITOI, S., KOH, T. and TAKI, T., Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res., 56, 1244-1249 (1996).
26. MULLER-PILLASCH, F., WALLRAPP, C., LACHER, U., FRIESS, H., BÜCHLER, M., ADLER, G. and GRESS, T.M., Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer. Gene, 208, 25-30 (1998).
27. NAKAJIMA-IIJIMA, S., HAMADA, H., REDDY, P. and KAKUNAGA, T., Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc. nat. Acad. Sci. (Wash.), 82, 6133-6137 (1985).
28. 1 at cell-cell contact sites. J. Cell Biol., 129, 1691-1705 (1995).
29. PELLEGATA, N.S., SESSA, F., RENAULT, B., BONATO, M., LEONE, B.E., SOLCIA, E. and RANZANI, G.N., K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res., 54, 1556-1560 (1994).
30. RADFORD, K.J., THORNE, R.F. and HERSEY, P., CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma. Biochem. biophys. Res. Comm., 222, 13-18 (1996).
31. SEEHAFER, J.G. and SHAW, A.R.E., Evidence that the signal-initiating membrane protein CD9 is associated with small GTP-binding proteins. Biochem. biophys. Res. Comm., 179, 401-406 (1991).
32. SZOLLOSI, J., HOREJSI, V., BENE, L., ANGELISOVA, P. and DAMJANOVICH, S., Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81 and CD82) at the surface of a B cell line JY. J. Immunol., 157, 2939-2946 (1996).
33. TAI, X.G., YASHIRO, Y., ABE, R., TOYOOKA, K., WOOD, C.R., MORRIS, J., LONG, A., ONO, S., KOBAYASHI, M., HAMAOKA, T., NEBEN, S. and FUJIWARA, H., A role for CD9 molecules in T cell activation. J. exp. Med., 184, 753-758 (1996).
34. TAKAHASHI, K. and SAWASAKI, Y., Rare spontaneously transformed human endothelial cell line, a useful research tool. In Vitro Cell. Develop. Biol. 28A, 380-382 (1992).
35. WEINEL, R.J., ROSENDAHL, A., NEUMANN, K., CHALOUPKA, B., ERB, D., ROTHMUND, M. and SANTOSO, S., Expression and function of VLA-alpha 2, -alpha 3, -alpha 5 and -alpha 6-integrin receptors in pancreatic carcinoma. Int. J. Cancer, 52, 827-833 (1992).
36. WRIGHT, M.D. and TOMLINSON, M.G. The ins and outs of the transmembrane 4 superfamily. Immunol. Today, 15, 588-594 (1994).